Theocharis Nikiforos Iordanidis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Theocharis Nikiforos Iordanidis has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Niclas Roxhed
Department of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden
5 shared publications - Göran Stemme
Department of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden
3 shared publications Argyris Spyrou
KTH Royal Institute of Technology, Division of Micro and Nanosystems Stockholm 100 44 Sweden
2 shared publications- Argyris Spyrou
Department of Micro and Nanosystems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm 100 44, Sweden
2 shared publications Göran Stemme
Department of Micro and Nanosystems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm 100 44, Sweden
2 shared publications- Xu Tian
KTH Royal Institute of Technology
2 shared publications
Latest Publications
- Open Access
MEMS-Based Ultrasonic Energy Harvesting Platform Enabling Sustained In Vivo Operation of Implantable Microdevices
Implantable microdevices capable of autonomous operation over extended lifetimes are promising enablers for minimally invasive diagnostics and therapy. Microelectromechanical systems (MEMS)-based piezoelectric ultrasonic energy harvesters (PUEH) have emerged as a compelling approach for powering implantable microdevices, where both miniaturization and efficient wireless energy transfer are essential. Here, we present a highly miniaturized (5 × 5 × 5 mm³) ultrasonic energy-harvesting platform enabling sustained in vivo operation of implantable microdevices. The platform integrates a MEMS-PUEH, a high-efficiency power management system, an energy storage element, and representative functional electronics. We first investigate the effect of backside cavity boundary conditions on MEMS-PUEH performance and show that a sealed air-filled chamber significantly outperforms an open water-filled cavity, yielding a 46% increase in root-mean-square output voltage and a 117% increase in average output power across a 2 kΩ resistive load under identical incident acoustic intensity at the respective optimal operating frequencies. We then demonstrate system-level integration and characterization. In a tissue-mimicking phantom, under an incident acoustic intensity of approximately 257 mW/cm 2 , the device charges an 11.5 mF supercapacitor, a 5 µAh solid-state microbattery, and a 100 µF capacitor to their nominal voltages in less than 5 min, 3 min, and 20 s, respectively. Finally, in vivo validation demonstrates fully autonomous operation of representative functional electronics following ultrasonic charging of the onboard energy storage element. These results establish a highly miniaturized and fully integrated ultrasonic energy-harvesting platform that advances MEMS-based power solutions for implantable biomedical microdevices.
Open AccessMEMS-Based Ultrasonic Energy Harvesting Platform Enabling Sustained In Vivo Operation of Implantable Microdevices
Implantable microdevices capable of autonomous operation over extended lifetimes are promising enablers for minimally invasive diagnostics and therapy. Microelectromechanical systems (MEMS)-based piezoelectric ultrasonic energy harvesters (PUEH) have emerged as a compelling approach for powering implantable microdevices, where both miniaturization and efficient wireless energy transfer are essential. Here, we present a highly miniaturized (5 × 5 × 5 mm³) ultrasonic energy-harvesting platform enabling sustained in vivo operation of implantable microdevices. The platform integrates a MEMS-PUEH, a high-efficiency power management system, an energy storage element, and representative functional electronics. We first investigate the effect of backside cavity boundary conditions on MEMS-PUEH performance and show that a sealed air-filled chamber significantly outperforms an open water-filled cavity, yielding a 46% increase in root-mean-square output voltage and a 117% increase in average output power across a 2 kΩ resistive load under identical incident acoustic intensity at the respective optimal operating frequencies. We then demonstrate system-level integration and characterization. In a tissue-mimicking phantom, under an incident acoustic intensity of approximately 257 mW/cm 2 , the device charges an 11.5 mF supercapacitor, a 5 µAh solid-state microbattery, and a 100 µF capacitor to their nominal voltages in less than 5 min, 3 min, and 20 s, respectively. Finally, in vivo validation demonstrates fully autonomous operation of representative functional electronics following ultrasonic charging of the onboard energy storage element. These results establish a highly miniaturized and fully integrated ultrasonic energy-harvesting platform that advances MEMS-based power solutions for implantable biomedical microdevices.
- Open Access
- 18 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 34 (5) , 691-700
Ultrasonic Selective Opening of Microcavities for Drug Delivery Microimplants
We present a fully passive, ultraminiaturized drug delivery microchip that enables wireless, on-demand release via ultrasonic actuation - a mechanism not previously demonstrated in implantable drug delivery systems. By eliminating the need for integrated power and control components, the device achieves sub-millimeter dimensions ( $\times 0.5$ mm $\times 1$ mm), enabling minimally invasive implantation in sensitive or hard-to-reach tissues. The system relies on ultrathin metallic membranes ( $\mu $ m wide, $2~\mu $ g of powder payload from individual microcavities in response to specific frequencies (360/420/580kHz), with membrane rupture occurring in in vivo conditions at ultrasonic intensities within clinically safe limits (2 ). This platform represents a significant step toward precise, programmable drug delivery in anatomically constrained or delicate regions.[2025-0104]
- 18 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 34 (5) , 691-700
Open AccessUltrasonic Selective Opening of Microcavities for Drug Delivery Microimplants
We present a fully passive, ultraminiaturized drug delivery microchip that enables wireless, on-demand release via ultrasonic actuation - a mechanism not previously demonstrated in implantable drug delivery systems. By eliminating the need for integrated power and control components, the device achieves sub-millimeter dimensions ( $\times 0.5$ mm $\times 1$ mm), enabling minimally invasive implantation in sensitive or hard-to-reach tissues. The system relies on ultrathin metallic membranes ( $\mu $ m wide, $2~\mu $ g of powder payload from individual microcavities in response to specific frequencies (360/420/580kHz), with membrane rupture occurring in in vivo conditions at ultrasonic intensities within clinically safe limits (2 ). This platform represents a significant step toward precise, programmable drug delivery in anatomically constrained or delicate regions.[2025-0104]
- Open Access
- 22 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (27) , e00990
Rolling Ultrasharp Microneedle Spheres Enable Topical Delivery of Biologics Through the Skin
Topical drug delivery offers a localized and patient‐friendly method for treating skin diseases and subcutaneous lesions. However, the outermost skin barrier ‐ the stratum corneum (SC) ‐ hinders the delivery of large molecules such as biopharmaceuticals. This study introduces rolling ultraminiaturized microneedle spheres (RUMS) as a novel solution that enables topical delivery of messenger RNA (mRNA) without the need for chemical enhancers or techniques like electroporation, iontophoresis, or microneedle patches. RUMS are engineered spherical microparticles that gently roll over the skin, creating numerous micropores while minimizing tissue damage. In ex vivo porcine skin experiments, 25 RUMS generated approximately 4,500 pores within 10 seconds, achieving penetration depths of around 20 micrometers and increasing skin permeability by up to 100‐fold. In vivo studies in mice showed that combining RUMS with topical doxycycline led to a ~50% tumor size reduction within two weeks and full recovery by four weeks. In contrast, doxycycline or RUMS alone offered limited therapeutic benefit. Rapid skin healing was observed due to the small pore size. Additionally, topical delivery of lipid nanoparticle‐encapsulated luciferase (luc)‐encoding mRNA was successfully demonstrated in mice. Overall, use of RUMS presents a simple, painless, and potentially well‐tolerated technique for enabling transdermal topical delivery of biologics.
- 22 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (27) , e00990
Open AccessRolling Ultrasharp Microneedle Spheres Enable Topical Delivery of Biologics Through the Skin
Topical drug delivery offers a localized and patient‐friendly method for treating skin diseases and subcutaneous lesions. However, the outermost skin barrier ‐ the stratum corneum (SC) ‐ hinders the delivery of large molecules such as biopharmaceuticals. This study introduces rolling ultraminiaturized microneedle spheres (RUMS) as a novel solution that enables topical delivery of messenger RNA (mRNA) without the need for chemical enhancers or techniques like electroporation, iontophoresis, or microneedle patches. RUMS are engineered spherical microparticles that gently roll over the skin, creating numerous micropores while minimizing tissue damage. In ex vivo porcine skin experiments, 25 RUMS generated approximately 4,500 pores within 10 seconds, achieving penetration depths of around 20 micrometers and increasing skin permeability by up to 100‐fold. In vivo studies in mice showed that combining RUMS with topical doxycycline led to a ~50% tumor size reduction within two weeks and full recovery by four weeks. In contrast, doxycycline or RUMS alone offered limited therapeutic benefit. Rapid skin healing was observed due to the small pore size. Additionally, topical delivery of lipid nanoparticle‐encapsulated luciferase (luc)‐encoding mRNA was successfully demonstrated in mice. Overall, use of RUMS presents a simple, painless, and potentially well‐tolerated technique for enabling transdermal topical delivery of biologics.
- Open Access
- 29 April 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101819
Ultraminiaturized neural implanted constructs display minimal immunologic response
- 29 April 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101819
Open AccessUltraminiaturized neural implanted constructs display minimal immunologic response
- 12 July 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 33 (5) , 524-531
Low-Temperature Fabrication of Millimeter-Scale MEMS-Based Piezoelectric Ultrasonic Energy Harvesters for Medical Implants
MEMS-based piezoelectric ultrasonic energy harvesters (PUEH) have become one of the most promising options for replacing or transferring energy to batteries in medical implants, where device miniaturization and power optimization are needed. Among the most commonly used piezoelectric materials in PUEH, lead zirconate titanate (PZT) is widely acknowledged for its excellent piezoelectric properties, good stability, and low cost. However, the performance of PZT degrades when the processing temperature approaches and exceeds half of its Curie temperature (T $_{\mathrm{c}})$ , limiting its application. Here, we demonstrate a highly miniaturized, low-temperature fabricated MEMS-based PUEH with an effective ultrasound harvesting area of 0.79 mm $^{2}$ and an effective device volume of 0.35 mm $^{3}$ . The low-temperature adhesive epoxy bonding ensures the temperature throughout the entire fabrication process remains below 85 $^{\circ}$ C, which preserves the properties of the integrated piezoelectric material to the greatest extent. This allows the use of bulk PZT-5H, a material that possesses superior piezoelectric properties, but has a relatively low T $_{\mathrm{c,}}$ to enhance device performance. Our device outputs a root-mean-square (RMS) voltage of 0.62 V and an RMS power of 0.19 mW on a 2 k $\Omega $ resistive load at an optimum operating frequency of 200 kHz, with a reception distance of 20 mm in water and input acoustic power intensity of 178 mW/cm $^{2}$ . The proposed design and fabrication technique enable our device to achieve the smallest effective size among the reported MEMS-based PUEH while still being capable of powering up numerous implantable medical devices and being compatible with various commercially available power management units. 2024-0081
- 12 July 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 33 (5) , 524-531
Low-Temperature Fabrication of Millimeter-Scale MEMS-Based Piezoelectric Ultrasonic Energy Harvesters for Medical Implants
MEMS-based piezoelectric ultrasonic energy harvesters (PUEH) have become one of the most promising options for replacing or transferring energy to batteries in medical implants, where device miniaturization and power optimization are needed. Among the most commonly used piezoelectric materials in PUEH, lead zirconate titanate (PZT) is widely acknowledged for its excellent piezoelectric properties, good stability, and low cost. However, the performance of PZT degrades when the processing temperature approaches and exceeds half of its Curie temperature (T $_{\mathrm{c}})$ , limiting its application. Here, we demonstrate a highly miniaturized, low-temperature fabricated MEMS-based PUEH with an effective ultrasound harvesting area of 0.79 mm $^{2}$ and an effective device volume of 0.35 mm $^{3}$ . The low-temperature adhesive epoxy bonding ensures the temperature throughout the entire fabrication process remains below 85 $^{\circ}$ C, which preserves the properties of the integrated piezoelectric material to the greatest extent. This allows the use of bulk PZT-5H, a material that possesses superior piezoelectric properties, but has a relatively low T $_{\mathrm{c,}}$ to enhance device performance. Our device outputs a root-mean-square (RMS) voltage of 0.62 V and an RMS power of 0.19 mW on a 2 k $\Omega $ resistive load at an optimum operating frequency of 200 kHz, with a reception distance of 20 mm in water and input acoustic power intensity of 178 mW/cm $^{2}$ . The proposed design and fabrication technique enable our device to achieve the smallest effective size among the reported MEMS-based PUEH while still being capable of powering up numerous implantable medical devices and being compatible with various commercially available power management units. 2024-0081